TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Not Yet Opened 04-28 16:00:00 EDT

2.10

+0.03

+1.45%

盘后2.10

+0.000.00%

18:13 EDT

High2.16	Low2.08	Vol10.08K
Open2.08	D1 Closing2.07	Amplitude3.86%
Mkt Cap24.31M	Tradable Cap20.08M	Total Shares11.57M
T/O21.42K	T/O Rate0.11%	Tradable Shares9.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":2.1,"timestamp":1777406400000,"preClose":2.07,"halted":0,"volume":10076,"hourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.1,"latestTime":"18:13 EDT","volume":15,"amount":31.3515,"timestamp":1777414421505,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014492753623188527,"floatShares":9560749,"shares":11574362,"eps":-0.05,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"04-28 16:00:00 EDT","open":2.08,"high":2.16,"low":2.08,"amount":21415.039994,"amplitude":0.038647,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.05,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777449600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":2.07,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":2.07,"latestTime":"05:42 EDT","volume":3,"amount":6,"timestamp":1777369334316,"change":-0.07,"changeRate":-0.033816,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.1,"latestTime":"18:13 EDT","volume":15,"amount":31.3515,"timestamp":1777414421505,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.514565,"impliedVol":0.4053,"impliedVolPercentile":0.1275},"requestUrl":"/m/hq/s/TXMD/tweets","defaultTab":"tweets","newsList":[{"id":"2631531714","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531714","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631531714?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:30","pubTimestamp":1777411800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 1.45% to $2.10 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.90% to 24,663.80 and Dow Jones Industrial Average  falling 0.05% to 49,141.93.TherapeuticsMD Inc. closed 28.81% below its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  rose 0.16% to $197.69.Trading volume  remained 12,917 below its 50-day average volume of 22,987.Data source: Dow Jones Market Data, FactSet. Data compiled April 28, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630310316","title":"TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630310316?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:33","pubTimestamp":1777321980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. shed 5.5% to $2.07 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 24,887.10 and the Dow Jones Industrial Average falling 0.1% to 49,167.79.The stock's fall snapped a two-day winning streak.TherapeuticsMD Inc. closed 29.8% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 0.7% to $197.38.Trading volume totaled 32,971, compared to the 50-day average of 23,656.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629075131","title":"TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2629075131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629075131?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:33","pubTimestamp":1776893580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 3.21% to $2.11 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.64% to 24,657.57 and the Dow Jones Industrial Average  rising 0.69% to 49,490.03.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 28.47% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc.  fell 2.25% to $200.50.Trading volume  remained 13,989 below its 50-day average volume of 25,793.Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629138776","title":"TherapeuticsMD Inc. Stock Rises 5.8%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2629138776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629138776?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:33","pubTimestamp":1776717180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. advanced 5.8% to $2.19 on what proved to be an all-around grim trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the NASDAQ Composite Index falling 0.3% to 24,404.39.The stock's rise snapped a three-day losing streak.TherapeuticsMD Inc. closed 25.8% short of its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its peers, as AbbVie Inc. fell 2.2% to $203.71.Trading volume totaled 29,766, compared to the 50-day average of 26,119.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627942222","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2627942222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627942222?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:30","pubTimestamp":1776202200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 2.93% to $2.11 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 1.96% to 23,639.08 and the Dow Jones Industrial Average  rising 0.66% to 48,535.99.TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  rose 1.84% to $210.26.Trading volume  eclipsed its 50-day average volume of 28,617.Data source: Dow Jones Market Data, FactSet. Data compiled April 14, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625092969","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2625092969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625092969?lang=en_us&edition=fundamental","pubTime":"2026-04-08 05:33","pubTimestamp":1775597580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 8.18% to $2.02 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.10% to 22,017.85 and the Dow Jones Industrial Average  falling 0.18% to 46,584.46.TherapeuticsMD Inc. closed 31.53% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  fell 0.15% to $206.37.Trading volume  remained 24,630 below its 50-day average volume of 42,188.Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625146601","title":"TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2625146601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625146601?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:32","pubTimestamp":1775507520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. jumped 10.0% to $2.20 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 21,996.34 and the Dow Jones Industrial Average rising 0.4% to 46,669.88.TherapeuticsMD Inc. closed 25.4% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its peers, as AbbVie Inc. fell 1.0% to $206.69.Trading volume totaled 30,271, compared to the 50-day average of 43,520.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624517299","title":"TherapeuticsMD Explains Brief Delay In Annual Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624517299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624517299?lang=en_us&edition=fundamental","pubTime":"2026-04-01 23:39","pubTimestamp":1775057962,"startTime":"0","endTime":"0","summary":"TherapeuticsMD ( ($TXMD) ) has released a notification of late filing. TherapeuticsMD, Inc. has filed a Form 12b-25 to notify investors of a brief ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-explains-brief-delay-in-annual-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-explains-brief-delay-in-annual-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594637","title":"TherapeuticsMD delays 2025 10-K after filing omits auditor report","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594637","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624594637?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:08","pubTimestamp":1775038129,"startTime":"0","endTime":"0","summary":"TherapeuticsMD filed a Form 12b-25, flagging a delay in its fiscal 2025 Form 10-K.Annual report filed March 30, 2026 omitted audit report for fiscal 2024 financial statements due to a printer error.Company refiled Form 10-K on April 1, 2026 with missing auditor report added.Refiling also included printer corrections, including updated hyperlinks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TherapeuticsMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL5W1HwG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555301","title":"TherapeuticsMD Inc. Stock Rises Tuesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555301","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555301?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:30","pubTimestamp":1774992600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 1.51% to $2.02 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 3.83% to 21,590.63 and the Dow Jones Industrial Average  rising 2.49% to 46,341.51.The stock's rise snapped a three-day losing streak.TherapeuticsMD Inc. closed 31.53% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  rose 2.05% to $217.49.Trading volume  remained 37,657 below its 50-day average volume of 53,020.Data source: Dow Jones Market Data, FactSet. Data compiled March 31, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623378662","title":"TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2623378662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623378662?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:12","pubTimestamp":1774915966,"startTime":"0","endTime":"0","summary":"The latest announcement is out from TherapeuticsMD ( ($TXMD) ). On March 30, 2026, TherapeuticsMD reported full-year 2025 results, showing net loss...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-narrows-2025-loss-advances-royalty-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-narrows-2025-loss-advances-royalty-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623322399","title":"TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2623322399","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623322399?lang=en_us&edition=fundamental","pubTime":"2026-03-31 06:10","pubTimestamp":1774908638,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 700 percent decrease over earnings of $0.01 per share from the same period last year.  The company reported $893.000 thousand in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51555962/therapeuticsmd-q4-eps-0-06-down-from-0-01-yoy-sales-893-000k-up-from-667-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623329751","title":"TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2623329751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623329751?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:34","pubTimestamp":1774902840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slipped 5.2% to $1.99 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 45,216.14 and the NASDAQ Composite Index falling 0.7% to 20,794.64.This was the stock's third consecutive day of losses.TherapeuticsMD Inc. closed 32.5% below its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. rose 1.8% to $213.12.Trading volume totaled 41,036, compared to the 50-day average of 54,248.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623532181","title":"TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2623532181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623532181?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:23","pubTimestamp":1774902239,"startTime":"0","endTime":"0","summary":"As of December 31, 2025, the Company’s cash and cash equivalents totaled $7.5 million. Published first on TheFly – the ultimate source for real-tim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-fy25-eps-6c-vs-20c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-fy25-eps-6c-vs-20c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326047","title":"TherapeuticsMD FY25 net loss from continuing operations narrows 73.91% to $0.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326047?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:07","pubTimestamp":1774901266,"startTime":"0","endTime":"0","summary":"TherapeuticsMD posted a net loss from continuing operations of $(0.7) million, narrowing by $1.7 million.Revenue rose 71.6% to $3 million, driven by changes in sales of licensed products under Mayne License Agreement.Total operating expenses declined 5.9% to $7.4 million.Cash and cash equivalents totaled $7.5 million at year-end.Strategic alternatives review continued, including potential acquisition, merger, business combination, or asset sale.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL8qj1dl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326090","title":"Press Release: TherapeuticsMD Announces Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326090?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:05","pubTimestamp":1774901100,"startTime":"0","endTime":"0","summary":"TherapeuticsMD, Inc.  , a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2025.--  Net loss from continuing operations was $(0.7) million, or $ per. basic and diluted common share, an improvement of $1.7 million, compared. to net loss from continuing operations of $(2.3) million, or $ per. --  License revenue, primarily from the Mayne License Agreement, totaled. $3.0 million during the year ended December 31, 2025, an increase of $1.3. million, or 71.6%, compared to $1.8 million in license revenue during the. year ended December 31, 2024. The increase is primarily attributable to. --  Total operating expenses for 2025 were $7.4 million, a decrease of $0.5. million, or 5.9%, compared to $7.9 million for 2024. The decrease was. TherapeuticsMD was previously a women's healthcare company with a mission of creating and commercializing innovative products to support the lifespan of women from pregnancy prevention thr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622868894","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868894?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:31","pubTimestamp":1774560660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 3.06% to $2.22 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 2.38% to 21,408.08 and Dow Jones Industrial Average  falling 1.01% to 45,960.11.TherapeuticsMD Inc. closed 24.75% below its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  rose 1.90% to $211.12.Trading volume  remained 57,802 below its 50-day average volume of 63,643.Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621508717","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2621508717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621508717?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:32","pubTimestamp":1774301520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 3.13% to $2.31 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.38% to 21,946.76 and the Dow Jones Industrial Average  rising 1.38% to 46,208.47.This was the stock's third consecutive day of gains.TherapeuticsMD Inc. closed 21.69% below its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 0.07% to $204.93.Trading volume  remained 50,367 below its 50-day average volume of 74,226.Data source: Dow Jones Market Data, FactSet. Data compiled March 23, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620240578","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2620240578","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620240578?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:31","pubTimestamp":1773783060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 2.76% to $2.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.47% to 22,479.53 and the Dow Jones Industrial Average  rising 0.10% to 46,993.26.TherapeuticsMD Inc. closed 24.41% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  fell 0.76% to $219.76.Trading volume  remained 55,519 below its 50-day average volume of 87,922.Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619148303","title":"TherapeuticsMD Inc. Stock Sheds 4.8%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2619148303","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619148303?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:32","pubTimestamp":1773433920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 4.8% to $2.17 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.9% to 22,105.36 and Dow Jones Industrial Average falling 0.3% to 46,558.47.This was the stock's third consecutive day of losses.TherapeuticsMD Inc. closed 26.4% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 2.5% to $219.68.Trading volume totaled 21,226, compared to the 50-day average of 89,782.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":-0.0548},{"period":"1month","weight":-0.0143},{"period":"3month","weight":-0.1446},{"period":"6month","weight":0.7107},{"period":"1year","weight":0.8},{"period":"ytd","weight":0.2699}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.069114},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.035452},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.013291},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.015308},{"month":5,"riseRate":0.538462,"avgChangeRate":0.005178},{"month":6,"riseRate":0.538462,"avgChangeRate":0.001172},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.043284},{"month":8,"riseRate":0.461538,"avgChangeRate":0.045617},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.025286},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.071876},{"month":11,"riseRate":0.615385,"avgChangeRate":0.054051},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.035764}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction